Background: Medicinal plant and plant products have shown tremendous potentials and are used beneficially in the treatment of inflammation and in the management of diseases with significant inflammatory components. Many medicinal plants employed as anti-inflammatory and antiphlogistic remedies lack the gastro-erosive side effects of non-steroidal anti-inflammatory drugs (NSAID) or the plethora of unwanted side effects associated with steroidal anti-inflammatory drugs. In order to harness and optimise the applications of these herbs in inflammatory diseases, there is a need to understand how these herbs produce their anti-inflammatory actions. Materials and Methods: This paper is a review of some anti-inflammatory herbs and their molecular mechanisms of action. A literature search and analysis of published manuscript was employed to x-ray research findings that show how medicinal plants produce anti-inflammatory activities. Results: Many studies have shown that anti-inflammatory activities of herbal extracts and herb-derived compounds are mainly due to their inhibition of arachidonic acid (AA) metabolism, cyclo-oxygenase (COX), lipo-oxygenase (LOX), pro-inflammatory cytokines, inducible nitric oxide, and transcription activation factor (NF-κB). Some anti-inflammatory medicinal herbs are reported to stabilize lysosomal membrane and some cause the uncoupling of oxidative phosphorylation of intracellular signalling molecules. Many have also been shown to possess strong oxygen radical scavenging activities. Conclusion: Most of the mechanisms by which anti-inflammatory medicinal plants act are related and many herbal products have been shown to act through a combination of these molecular pathways.
Introduction
There are several proposed cellular actions or mechanisms explaining in vivo anti-inflammatory activity of medicinal plants. These mechanisms include antioxidative and radical scavenging activities, regulation of cellular activities of the inflammation-related cells: mast cells, macrophages, lymphocytes, and neutrophils (for instance, some inhibit histamine release from mast cells and others inhibit T-cell proliferation), modulation of the enzymatic activities of arachidonic acid (AA) metabolizing enzymes such as phospholipase A2 (PLA2), cyclooxygenase (COX), and lipoxygenase (LOX) and the nitric oxide (NO) producing enzyme, nitric oxide synthase (NOS) (Vane and Botting, 1987; Chen, 2011) . Inhibitions of these enzymes by anti-inflammatory medicinal plants products (AIMP) reduce the production of AA, prostaglandins (PG), leukotrienes (LT), and NO, which are crucial mediators of inflammation (Khanapure et al., 2007) . Thus, the inhibition of these enzymes by AIMP is one of the important cellular mechanisms of anti-inflammation. In recent years, many lines of evidence support the idea that certain AIMP are the modulators of gene expression, especially the modulators of pro-inflammatory gene expression, thus leading to the attenuation of the inflammatory response. Here, we have highlighted the relevance of these mechanisms as they relate to the activities of herbal products used in the treatment of inflammation.
Inhibition of Phospholipase A2
During inflammatory response, arachidonic acid (AA), a precursor of eicosanoids, is released mostly from membrane lipids in cells. The enzyme responsible for this release is Phospholipase A2 (PLA2), although some portion is attributed to the combined action of phospholipase C and diacylglycerol lipase (Ito et al., 2002) . AA mobilization by PLA2 and subsequent prostaglandins synthesis is considered to be a pivotal event in inflammation. Therefore, drugs that inhibit PLA2 thus block the cyclo-oxygenase (COX) and lipo-oxygenase (LOX) pathways in the AA cascade are effective in the treatment of inflammatory processes. PLA2 catalyses the hydrolysis of the acyl group attached to the 2-position of intracellular membrane phosphoglycerides which releases arachidonic acid from membrane phosphoglycerides. Arachidonic acid is the precursor of prostaglandins (PGs), thromboxanes, and leukotrienes. Some anti-inflammatory medicinal plants inhibit PLA2 ( Figure 1 ) and this inhibition is mediated via lipocortine or by direct interaction with the enzyme itself. The former mechanism utilizes a protein known as lipocortine, the synthesis of which is induced by steroidal hormones and steroidal plant metabolite, triterpenoids (Barnes, 1998) . The other mechanism involves a direct binding with the enzyme itself, a mechanism that is yet to be exploited in therapeutics but with great promise. It is known that betulinic acid, a triterpene act by direct binding to phospholipase A2 (Wiart, 2006) .
The inhibitory activity of several flavonoid derivatives against AA metabolizing enzymes was initially reported in 1980 (Bauman et al., 1980) . Thereafter, investigators have studied the inhibitory effect of flavonoids on these enzymes (Kim et al., 2004) . Up to date, many isoforms of PLA2 have been discovered (Murakami and Kudo, 2004) . They are mainly classified into three large categories, secretory PLA2 (sPLA2), cytosolic PLA2 (cPLA2), and calcium independent PLA2 (iPLA2). These PLA2s are distributed in wide varieties of tissues and cells. In some conditions, they are coupled to COXs depending on the cells and agonists used (Murakami and Kudo, 2004) . For instance, group IIA sPLA2 was found in arthritic synovial fluid, and group IV cPLA2 are coupled to COXs and 5-LOX to produce eicosanoids (Murakami and Kudo, 2004) . Therefore, a modulation of sPLA2 and/or cPLA2 activity is important in the control of inflammatory processes.
The first flavonoid inhibitor of PLA2 to be identified was quercetin, which inhibited PLA2 from human neutrophils (Lee et al., 1982 Quercetin was repeatedly found to inhibit PLA2 from several sources. It inhibited PLA2 from rabbit peritoneal neutrophils with an IC50 of 57100 µM (Lanni and Becker, 1985) . It was also demonstrated that quercetin selectively inhibited group II sPLA2 from Vipera russelli with less inhibition of PLA2 from porcine pancreas, PLA2-IB (Lindahl and Tagesson, 1993) . While flavanones including flavanone, hesperetin, and naringenin showed less inhibition, flavonols such as kaempferol, quercetin, and myricetin were found to considerably inhibit snake venom PLA2, indicating an importance of the C-ring-2,3-double bond (Welton et al., 1986) . In many other studies, other herbal extracts and phytoconstituents have been reported to exhibit significant anti-inflammatory effects through an inhibition of various PLA2. Extract of Trichilia catigua (Meliaceae) completely inhibited PLA2 at a concentration of 120 µg/ml (Barbosa et al., 2004) . Ethanol extract of Baccharis uncinella DC (Asteraceae) were reported to contains among other constituents two triterpenoids (oleanolic and ursolic acids) and one flavonoid (pectolinaringenin) which exhibited anti-inflammatory effects against inflammatory reactions induced by phospholipase A2 (from Crotalus durissus terrificus venom) (Zalewski et al., 2011) . It was shown recently that the water extract of Aloe vera leaf skin (AVLS) extract exhibited anti-PLA2 activity with an IC50 = 0.22 mg/ml (Kammoun et al , 2011) . Also recently, it was shown that the neuroprotective effect of Ginkgo biloba extract (EGb761) was mediated, at least in part, through inhibition of cytosolic cPLA2 activation (Zhao et al., 2011) . In a study to evaluate the effects of the flavonoid, quercetin, on Crotalus durissus terrificus secretory phospholipase A2 (sPLA2), it was reported that the protein was chemically modified by treatment with quercetin, which resulted in modifications in the secondary structure as evidenced through circular dichroism (Kim et al., 2004) . In addition, quercetin was able to inhibit the enzymatic activity and some pharmacological activities of sPLA2, including its antibacterial activity, its ability to induce platelet aggregation, and its myotoxicity by approximately 40% (Cotrim et al., 2011) . Cochinchina momordica seed extract (SKMS10) was also shown to exhibit anti-inflammatory activities by down-regulating cPLA2 among other molecular mechanisms of action (Kang et al., 2009 ). " and " " denote enzyme inhibition and down-regulation of the expression, respectively.
Inhibitors of cyclooxygenases (COX)
COX that produces prostaglandins (PGs) and thromboxanes (TX) from arachidonic acid exists in two different isoforms (COX-1 and -2). COX-1 is a constitutive enzyme existing in almost every cell type, catalysing the conversion of AA into cytoprotective PGs and blood proaggregatory TXs. On the other hand, COX-2 is an inducible enzyme and in most cases causes the production of large amount of PGs (Needleman and Isakson, 1997) . COX-2 is highly expressed in the inflammation-related cell types including macrophages and mast cells, when they are stimulated with pro-inflammatory cytokines and/or bacterial lipopolysaccharide (LPS) (Needleman and Isakson, 1997) . Inhibition of both COX-1 and COX-2 has been found to be the molecular target of many anti-inflammatory herbal extracts and herb-.derived compounds (Figure 1 ). COX-2 that produces PGs is closely associated with inflammatory disorders of acute as well as chronic types. Actually, COX-2 selective inhibitors possess anti-inflammatory activity with reduced side effects frequently seen with COX-1/COX-2 non-selective inhibitors (McMurray and Hardy, 2002 Devil's claw, Harpagophytum procumbens DC (Pedaliaceae) used in South Africa for the management of pain and inflammation is an example of medicinal plant whose anti-inflammatory activities is based on reported inhibition of COX (Kundu et al., 2005) . Anti-inflammatory effects of seven lignans and one dihydrochalcone isolated from the leaves of two Lauraceae species (Pleurothyrium cinereum and Ocotea macrophylla), were found to be potent inhibitors of COX-2/5-LOX (Coy-B arrera and Cuca-Suarez, 2011). Ethyl acetate-soluble extract of the stems of Macrococculus pomiferus was found to inhibit COX-2 . (S)-coriolic acid and (+/-)-glycerol 1-monolinolate isolated from ethylacetate-soluble extract of the seeds of Hernandia ovigera showed selective inhibitory activity with cyclooxygenase-2 (Jang et al., 2004) . The compound, 2, 4, 5-trimethoxybenzaldehyde isolated from Daucus carota seed extracts inhibited COX-2 enzyme very significantly at a concentration of 100 μg/ml (Momin et al., 2003) . Some flavonoids such as luteolin, 3', 4'-dihyroxyflavone, galangin, and morin were found as inhibitors of COX (Bauman et al., 1980) . When their structural activity relationships were compared, several flavone derivatives such as flavone and apigenin were found to be COX inhibitors, while some flavonol derivatives such as quercetin and myricetin were preferential LOX inhibitors. Also, certain flavonoids such as flavone, kaempferol, and quercetin were repeatedly found to be inhibitors of COX from rat peritoneal macrophages (Welton et al., 1986) . After these reports, many studies have been done to figure out the inhibitory activity of flavonoids on COX, mostly COX-1. For instance, flavonoids such as quercetin and xanthomicrol were reported to inhibit sheep platelet COX-1; while the IC50 values of flavones such as cirsiliol, hypolaetin, and diosmetin were more than 100 µM (Ferrandiz et al., 1990) . Furthermore, flavones and flavonols including chrysin, flavone, galangin, kaempferol, and quercetin were repeatedly revealed to inhibit TXB2 formation from mixed leukocyte suspension probably by COX-1 inhibition (Laughton et al., 1991) .
Inhibition of lipooxygenases (LOX)
Arachidonate 5-lipoxygenase is the key enzyme in leukotriene biosynthesis and catalyses the initial steps in the conversion of arachidonic acid to biologically active leukotrienes. Leukotrienes are considered as potent mediators of inflammatory and allergic reactions, and regarding their pro-inflammatory properties the inhibition of 5-lipoxygenase pathway is considered to be interesting in the treatment of a variety of inflammatory diseases. Lipooxygenases (LOX) are present in leucocytes, tracheal cells, keratinocytes, and the epithelium of stomach and airways and they catalyse the introduction of a molecule of oxygen to the 5-position of AA to give the intermediate 5(S)-hydroxy-(6E, 8Z, 11Z, 14Z)-eicosatetraenoic acid, 5-HETE, which is immediately followed by the re-arrangement of 5-HETE to leukotrienes. This is another target for antiinflammatory medicinal plants that inhibit the biogenesis of leukotrienes and 5-HETE ( Figure 1 ). Medicinal plants that inhibit LOX hold some other useful therapeutic potential in the treatment of asthma, psoriasis, arthritis, allergic rhinitis, cancer, osteoporosis, and artherosclerosis. A potential source for new 5-lipoxygenase inhibitors is undoubtedly provided by medicinal plants used in traditional medicine. The Arisia species and other Myrsinacea family produce very unusual series of dimeric benzoquinones known as ardisiaquinones, which are known to inhibit the enzymatic activity of 5-LOX. This feature could explain the frequent use of Ardisia species to treat inflammatory conditions. One such compound is Ardisiaquinone G which was isolated from Ardisia teysmanniana and is known to inhibit LOX (Yang et al., 2001; Fuuishi et al., 2001) . The Asteraceae family is one of the richest source of LOX inhibitors and three different types of principles exhibiting remarkable LOX inhibition have been isolated and characterised. Helenalin, a sesquiterpene lactone, which can be isolated from several plant species of the Asteraceae family possess potent anti-inflammatory and antineoplastic agent. Helenalin inhibited 5-LOX (IC50 9 mM after 60 min preincubation) in a concentration and time-dependent fashion in human granulocyte culture (Tornhamre et al., 2001) . Polyacetylenes from Artemisia monosperma showed some levels of activity against LOX (Stavri et al., 2005) . The third groups of LOX inhibitors in this family are the bornyl cinnamoyl derivatives from Verbenisa species, such as bornyl caffeate from the South American herb Verbenisa turbacensis Kunth. Another compound, friedelin isolated from the bark of Commiphora berryi showed significant soybean lipoxygenase (SBL) inhibitory activity with IC50 of 35.8μM (Kumari et al., 2011) .
Generally, an enormous number of different plant-derived compounds from various species have been found to interfere with 5-LOX activities. In general, it appears that lipophylic, often fatty acid-like compounds with (i.e. phenols) and without (i.e. triterpenes and polyacetylenes) reducing properties interfere with 5-LOX and the majority are phenolic structures including flavonoids, quinones, (that become hydroxylated to hydroquinones), hydroxylated coumarines, and many other polyphenols. Apparently a combination of iron-reducing and ironchelating properties of these phenolic compounds is responsible for 5-LOX inhibitions (Werz, 2007) 
Inhibition of nitric oxide synthetase (NOS)
The NOS is an important enzyme involved in the regulation of inflammation, vascular tone, neurotransmission, and cancer. NO is a toxic free radical that can cause substantial tissue damage in high concentration. In stroke, large amount of NO is released from nerve cells and causes extensive damage to surrounding tissues including neurones and myocytes (Shah et al., 2011) The NO is biochemically generated via oxidation of the terminal guanidine nitrogen atom from L-arginine by NOS. NO is one of the cellular mediators of physiological and pathological process (Moncada et al., 1991; Nathan, 1992; Mollace et al., 2005) . Three different isoforms of NOS are now recognised: endothelial NOS (eNOS), neuronal NOS (nNOS), and inducible NOS (iNOS) (Venema et al., 1997; Stuehr, 1999) . The former two are constitutively expressed in the body, whereas the latter type is an inducible enzyme highly expressed by inflammatory stimuli in certain cells such as macrophages. iNOS is involved in overproduction of NO in response to pro-inflammatory mediators such as interleukine-1f3 (IL-1f3), tumour necrosis factor-α (TNF-α), and bacterial lipopolysaccharide (LPS). While a small amount of NO synthesized by eNOS and nNOS is essential for maintaining normal body function (homeostasis), a significantly increased amount of NO synthesized by iNOS participates in provoking inflammatory process and acts synergistically with other inflammatory mediators (Mollace et al., 2005) . Many herbal extracts and compounds of herbal origin have shown strong inhibition of iNOS and NO overproduction ( Figure 1 ). Search for herb-based compounds which can reduce NO production by inhibiting iNOS without affecting eNOS or nNOS is very desirable for anti-inflammatory agents.
Recently, we reported the inhibition of inducible NO production by the methanol extract of Spondias mombin (Nworu et al., 2011) .
LPS-stimulated NO production by bone marrow-derived macrophages was significantly inhibited at 25 μg/ml and 100 μg/ml of the methanol extract (Nworu et al., 2011 (Lee et al., 2002) . Inhibition of iNOS is not a general behaviour of flavonoids, but they inhibit NO production which means they down-regulate the expression of iNOS and not the activity of already produced enzymes. Flavone and several other amino-substituted flavones were reported to inhibit NO production (Krol et al., 1995) . Flavonoids that down-regulate iNOS expression include flavones such as apigenin and oroxylin A; flavonols such as kaempferol and quercetin; biflavonoids such as bilobetin and ginkgetin, and some prenylated flavonoid such as sanggenons and kuwanon C (Kim et al., 2004) .
Inhibitions of pro-inflammatory cytokines
Several cytokines are associated with inflammatory diseases. A number of pro-inflammatory cytokines also regulate inflammatory reactions either directly or by their ability to induce the synthesis of cellular adhesion molecules or other cytokines in certain cell types. The major pro-inflammatory cytokines that are responsible for early responses are IL1-alpha (IL-1α), IL1-beta (IL-1 f3), IL-6, and TNF-alpha (TNF-α). Other pro-inflammatory mediators include leukemia inhibitory factor, (LIF), interferon-gamma (IFN-γ), oncostatin M (OSM), ciliary neurotrophic factor (CNTF), tumour growth factor-beta (TGF-f3), granulocyte macrophage colony-stimulating factor (GM-C SF), IL-8, IL-11, IL-12, IL-17, IL-18, and a variety of other chemokines that chemoattract inflammatory cells. Inhibition of the expression of these cytokines has been demonstrated as the target for many antiinflammatory medicinal plants and their compounds ( Figure 1 ; Table 1 ). Steroidal anti-inflammatory drugs (SAIDs) such as prednisolone and dexamethasone are also known to reduce the production of these pro-inflammatory cytokines (Newton, 2000) .
Modulation of pro-inflammatory gene expression
The cellular mechanisms through which anti-inflammatory medicinal plants modulate gene expression have also been extensively studied. The most prominent points of cellular regulation affected by these herbs and herb-based compounds are the various protein kinases involved in signal transduction including protein kinase C (PKC) and mitogen activated protein kinase (MAPK) (Figure 1 (Kim et al., 2004) . Thereby, the expression rate of the target gene is controlled. Flavonoids inhibit the enzyme activities of various signal transduction protein kinases (Kim et al., 2004) . The best example is PKC inhibition (Ferriola et al., 1989) and protein tyrosine kinase inhibition (Chang and Geahlen, 1992) by various flavonoid derivatives. MAPKs are also key elements in signal transduction. In macrophages, LPS activates three kinds of MAPKs, extracellular signal related kinase (ERK), p38 MAPK, and Jun N-terminal kinase/ stress activated protein kinase (JNK/SAPK) (Weinstein et al., 1992) . It was shown that a plant flavonoids, quercetin, inhibited inducible nitric oxide sythethase (iNOS) expression by inhibiting p38 MAPK ) and inhibited TNF-α -induction from LPS-induced RAW cells by inhibiting JNK /SAPK, leading to the inhibition of AP-1-DNA binding . In a separate pathway, quercetin inhibited ERK 1/2 and p38 MAPK to regulate the post-transcriptional level of TNF-α. It has been shown that quercetin inhibited NF--ƙB activation by ERK and p38 kinase inhibition (Cho et al., 2003) . Another plant flavonoid, wogonin, inhibited monocyte chemotactic protein-1 gene expression of 12-Otetradecanoylphorbol 13-acetate (TPA)-induced human endothelial cells by AP-1 repression through ERK 1/2 and JNK inhibition (Chang et al., 2001) .
Studies have shown clearly that anti-inflammatory medicinal plants inhibited the expression of various inflammation-related proteins/enzymes, at least partly, by suppressing activation of transcription factors such as NF-KB and AP-1 (Kim et al, 2004) . These suppressions might be mediated via inhibition of several protein kinases involved in the signal transduction pathway. 
SOME NIGERIAN ANTI-INFLAMMATORY HERBS
The use of anti-inflammatory herbs for health improvement has a long and successful history in traditional medicine in Nigeria. Many herbal preparations are used to treat fever and inflammation in the traditional folklore medicine. The hope of discovering novel therapeutic agents capable of suppressing, reducing, or relieving pain as well as inflammation is high.
Many human and animal diseases, such as arthritic disorders, lupus erythematosus, asthma, bronchitis, inflammatory bowel disease, ulcerative colitis, pancreatitis, ascities, hepatitis, cancer, infections are associated with different degrees of inflammation. Malaria and malaria fever can also be viewed as inflammatory disorders (Perlmann and Troye-Blomberg, 2000) . The infection of the liver and the red blood cells by the hepatic and erythrocytic plasmodia schizonts leads to severe inflammation of hepatocytes. The clinical manifestations of malaria, fever and chills, are associated with the synchronous rupture of the infected erythrocytes and the release of metabolites with potent pro-inflammtory activities (Perlmann and Troye-Blomberg, 2000) . For this reason, antipyretic and anti-inflammatory therapies are often essential in the treatment of malaria. This could explain the benefits and instant relive experienced by malaria patients when they use anti-inflammatory medications, including some herbal medications with known antiphlogistic properties. The treatment of rheumatic disorders (inflammation) is one area in which Nigerian traditional medical practitioners enjoy patronage and success. A good number of plant species are available for this purpose, and the method of usage differs from one area to another. The most common practice involves taking the extracts orally as decoctions or infusions; washing the inflamed part (e.g. swollen knee) with the extracts; applying squeezed herb as poultice on inflamed part (Akah and Nwambie, 1994; Akah et al., 2003a,b; Akah et al., 2004 Akah et al., , 2007 . Evaluation and understanding the mechanisms behind the anti-inflammatory activities of some of these medicinal plants has been the focus of some of our recent studies (Nworu et al., 2011 (Nworu et al., , 2012 Okoye et al., 2013) . These medicinal plants have been the focus. Some of these local medicinal plants which have been used in folklore medicine to treat inflammation, fever, and rheumatic ailments are shown in Table 3 .
Conclusion
Inflammation acts as a central executor in the pathogenesis of many diseases such as rheumatoid arthritis, arteriosclerosis, myocarditis, infections, cancer, metabolic disorders, and many more. Monocytes and macrophages are the key players in inflammatory responses and are also the major sources of pro-inflammatory mediators and enzymes including tumour necrosis factor-a (TNF-α), interleukins (ILs), cyclooxygenase (COX), and nitric oxide synthase (NO S). These genes of pro-inflammatory mediators are strongly induced during inflammation and are responsible for its initiation and persistence. TNF-α and IL-1β are the cytokines that act as signalling molecules for immune cells and coordinate the inflammatory responses. Cyclooxygenase-2 (COX-2) is an enzyme which is necessary for the production of pro-inflammatory prostaglandins and thus has been a target for many present anti-inflammatory medicinal plants. Nitric oxide (NO) is a free radical that mediates many physiological and pathophysiological processes, including neurotransmission and inflammation. Expression of the inducible isoform of NOS (iNOS) in activated macrophages is mainly responsible for production of pathological concentration of NO during inflammation. Therefore suppression of iNO synthetase expression is an important target through which many anti-inflammatory medicinal plants mediate their activities. It is established that nuclear factor-κB (NF-κB) and AP-1 play the most important roles in the immune system. NF-κB is reported to regulate the expression of nearly all inflammatory mediators involved in inflammation. Nuclear translocation of NF-κB and AP-1 in response to various proinflammatory stimuli is associated with the activation of inflammatory cascade and therefore, these transcriptional factors are primary target of many anti-inflammatory medicinal plants and their compounds.
Since anti-inflammatory medicinal plant extracts are usually multi-component, it is likely that they act on multiple targets to impact the complex equilibrium of whole cellular networks of immune cells. This could be more favourably than agents that act on a single target since complementary actions on many genes might be needed to modify inflammatory disease processes. In other words, the efficacy of herbal therapy and herb-based anti-inflammatory compounds might depend on the perturbation of more than one target.
